ClinicalTrials.gov and FDAAA for NIH Extramural Grants Gwynne L. Jenkins, PhD, MPH Special Assistant to the Director Office of Extramural Programs, OER.

Slides:



Advertisements
Similar presentations
Research Performance Progress Report (RPPR) Grantees may access a list of progress reports that are due using the Status page in eRA Commons, and selecting.
Advertisements

SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
Strengthening the Medical Device Clinical Trial Enterprise
 August 14, 2012 Office of Extramural Research National Institutes of Health, HHS Scarlett Gibb, Customer Relationship Manager, eRA Commons Kathy Hancock,
Using MyNCBI for Training Grants Stephanie Scott Communications and Outreach Director Sponsored Projects Administration (SPA) Dina Matsoukas Head of Reference.
The NIH Public Access Requirement March 2014 Tara Douglas-Williams, MSLS.
NIH Public Access Policy Bethany R. Harris, MSI Research Librarian for Health Sciences Sponsored by the UCI Libraries’ Digital Services Operations Team.
Complying with the NIH Public Access Policy Lisa Oberg, M. Libr. Associate Director for Public and Research Services.
Preparing and Submitting Reports Della Brown White, Ph.D. Program Officer, Office of Health Equity Eunice Kennedy Shriver National Institute of Child Health.
NOVEMBER 19, 2013 PRE-AWARD TOPICS MODULE SESSION 8 OF SERIES III AAPLS (APPLICANTS & ADMINISTRATORS PRE-AWARD LUNCHEON SERIES) How to Use eRA Commons.
NIH Public Access Policy What it means to OHSU Researchers Presented by: Andrew Hamilton Date: 10/22/2009.
NCI Clinical Trials Reporting Program CTRP User Meeting November 2, 2011 Gene Kraus CTRP Program Director.
NIH Public Access Policy: RPPR and MY NCBI Amanda Snyder, Assistant Director, SPA Alexa Mayo, Associate Director, HS/HSL April 24, 2013.
NIH Research Performance Progress Report (RPPR)
Research Integrity at the NIH
Clinical Trials Registry Susan Koenig, MPP&PA Director, Office of Compliance & Quality University of Missouri-Columbia School of Medicine Compliance &
UNIFORM GUIDANCE OVERVIEW. OMB Circulars Before and After A-21 Cost principles for Educational Institutions A-21 Cost principles for Educational Institutions.
NIH Public Access Policy What it means to OHSU Researchers Presented by: Andrew Hamilton Date: 3/18/2007.
Instructions for VCU’s Internal Approval Form Form is required to obtain Authorized Official’s signature on proposals and awards OSP – 8/2006.
1 NIH Public Access Policy Policy on Enhancing Public Access to Archived Publications Resulting From NIH-Funded Research (Public Access Policy)
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
When to Route a Proposal Sponsored Projects Services Uaccess Learning: UA
11 February 2008NLM BOR WG on Clinical Trials1 Clinical Trials Registration and Results Reporting: Legislative Requirements Jerry Sheehan Assistant Director.
CTRP User Call April 3, 2013 Gene Kraus CTRP Program Director.
 Presented By: NameTitleOffice PresentationTitle NIH Regional Seminar May 7, 2015 David Curren Special Assistant to the Office Director Officer of Policy.
Hartford Hospital Research Institute Time and Effort Reporting Prepared By: HHC Office of Compliance, Audit and Privacy Angelo Quaresima, Research Compliance.
ERA Commons and Progress Reports How PIs and the NIH Communicate Elisa Woodhouse Division of Cancer Biology New Grantee Workshop March 12, 2014.
New Faculty Orientation August 22, 2012 UAMS Research Support Center Director: Tom Wells (501)
NIH Implementation and Guidance Syracuse University Office of Sponsored Programs Stuart Taub.
Complying with the NIH Public Access Policy: From Soup to Nuts
DCB New Grantee Workshop: Post-Award Administration of Grants Brett Hodgkins Team Leader National Cancer Institute Office of Grants Administration.
Got the Grant What’s next??????????? Joy R. Knipple Team Leader, National Institute of Mental Health July 26, 2006.
POST-AWARD GRANT MANAGEMENT June 23, 2014 Presented by Arina V. Kramer Grants Management Specialist Office of Grants Administration, NCI.
Office of the Vice Chancellor for Research 1 Update on PHS New Rule on Financial Conflicts of Interest (FCOI) Presentation to Business Managers January.
CTMO Lunch & Learn ClinicalTrials.gov February 24, 2015.
DCB New Grantee Workshop: Post-Award Administration of Grants Brett Hodgkins Team Leader National Cancer Institute Office of Grants Administration.
1 Investigating Fraud & Abuse Violations in Medical Research Janet Rehnquist, Esq. Venable LLP th Street, NW Washington, DC
NIH UPDATE Reference: NOT-OD Error correction window REDUCED from 5 to 2 business days Proposal “on time” if ALL of the following are met Registrations.
DOMESTIC AND FOREIGN SUBCONTRACTS/SUBAWARDS CITI Training.
BERNARD BECKER MEDICAL LIBRARY Washington University School of Medicine December 2008 The NIH Public Access Policy How to Demonstrate Compliance RA Forum.
DCB New Grantee Workshop: Post-Award Administration of Grants Brett Hodgkins Team Leader National Cancer Institute Office of Grants Administration.
A service of the U.S. National Institutes of Health Module 3: The Librarian’s Role in Advocating to Clinical Researchers.
FEDERAL UPDATE Jeff Warner Senior Contract and Grant Officer Alisia Ford Contract and Grant Officer Spring QRAM - Tuesday, March 12, 2013.
 Presented By: NameTitleOffice PresentationTitle NIH Regional Seminar June 26, 2014 David Curren Special Assistant to the Office Director Officer of Policy.
JEFF WARNER CONTRACT AND GRANT OFFICER FEDERAL UPDATE.
Clinical Research Training Center Office of Training Grants RPPR: Training Grant Focus Training Grant Administrators Working Group July 8, 2015.
CTRP User Call November 13, 2013 Gene Kraus CTRP Program Director.
Melissa McCarey, MPH Jefferson Clinical Research Institute (JCRI) Clinicaltrials.gov: What is it? What do I need to know?
ClinicalTrials.gov and FDAAA for NIH Grantees NIH Regional Seminar – October 2015 Rebecca J. Williams, Pharm.D., MPH Assistant Director, ClinicalTrials.gov.
Ver. 02/13/  Registration  New Studies  Continuing Reviews  Amendments  Reportable Events  Tips & Tricks  Questions 2.
CTRP User Call May 1, 2013 Gene Kraus CTRP Program Director.
1 The NIH Public Access Requirement [short presentation] June 2013.
Research as defined by DHHS A systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable.
COBRE Post Award Management Christy Leake Grants Administration Branch National Institute of General Medical Sciences, NIH.
Research Administration Updates
Emily Ouellette, JD Assistant Director, Partners QI Program
Objectives 1. Define and describe each of the Agreement types being discussed today; 2. Highlight specific questions to ask when determining the administrative.
ClinicalTrials.gov Requirements
Clinicaltrials.gov Update
FDA’s IDE Decisions and Communications
Ceding Review: Using the new SmartIRB Online Reliance System
ClinicalTrials.gov: An introduction
IRB Compliance Program PRS Administrator, Brian Brotzman
NIH Public Access Policy: RPPR and MY NCBI
ClinicalTrials.gov PRS – How to Register and Maintain a Record
New NIH Human Subjects & Clinical Trials Information
IRB Compliance Program PRS Administrator, Brian Brotzman
ClinicalTrials.gov PRS – How to Register and Maintain a Record
ClinicalTrials.gov PRS – How to Register and Maintain a Record
CTSA27 So you want COMIRB to be your sIRB: What you need to know.
Presentation transcript:

ClinicalTrials.gov and FDAAA for NIH Extramural Grants Gwynne L. Jenkins, PhD, MPH Special Assistant to the Director Office of Extramural Programs, OER NIH Regional Seminar – June 28,

Objectives for This Section 1. Help you understand compliance: –Responsible Party (RP) role for applicable clinical trials (ACTs) supported by NIH grants –NIH certification of compliance with FDAAA 2. Help you avoid trouble spots: –Resources to help you –Tips Note: NIH extramural grants only; not NIH contracts. 2

3 The NIH encourages registration and results reporting for all NIH-supported clinical trials, regardless of whether or not they are subject to FDAAA.

Responsible Party & NIH Grants Sponsor [only one per trial] is: –IND/IDE* holder; if none, then: –The Grantee Institution is generally considered to be the Sponsor Grantee is the “initiator” of the trial, having submitted the funding proposal – pdfhttp://prsinfo.clinicaltrials.gov/ElaborationsOnDefinitions. pdf –Note: Includes cooperative agreements & Center grants 4 * Investigational New Drug/Investigations Device Exemption

Criteria for PI as Responsible Party Sponsor may designate the PI of the clinical trial as RP provided that she or he: 1.Is responsible for conducting the trial; 2.Has access to and control over the data from the clinical trial; 3.Has the right to publish the results of the trial; and 4.Has the ability to meet all of the requirements for submitting information under the law. PI must meet all criteria to be designated 5

Designating the PI as RP (or Not) Sponsor is not required to designate the PI as the RP Carefully consider the implications of designating a PI as RP –What is in the best interest of the Sponsor? –After the trial ends? –After the PI leaves? 6

Understanding the Requirement to Certify Compliance All ACTs supported in whole or in part by an NIH grant must be in full compliance with FDAAA –The RP has made all required submissions to ClinicalTrials.gov NIH certification of compliance with FDAAA applies to: –All grants supporting ACTs (even if only in part) –Grants where neither grantee nor PI is the RP of the ACT 7

Certifying of Compliance to NIH Competing awards (applications): SF 424: Part II, section 4.1.6SF 424 PHS 398: Part II, section 4.1.6PHS 398 Non-competing continuation progress reports: PHS 2590: Section D and section 4.6PHS 2590 –For non-Streamlined Non-competing Award Process (SNAP) awards Research Performance Progress Report (RPPR): –all SNAP awards –all F awards with start dates on or after July 1, 2013 –Stay tuned for non-SNAP awards later in Unrelated to the FDA certification of compliance 8

NIH Certification of Compliance: Competing applications and PHS 2590 In the “Human Subjects” section Add a heading entitled “ClinicalTrials.gov” Under the heading, registered trials provide: –NCT number/s –Brief Title/s –ID and contact info for the RP Under the heading, trials not yet registered (<21 days since enrollment of the first participant): –Include a clear statement that the project includes an ACT which will require registration in ClinicalTrials.gov. 9

Section G. Special Reporting Requirements G.4.c ClinicalTrials.gov Does this project include one or more applicable clinical trials that must be registered in ClinicalTrials.gov under FDAAA? YesNo If yes, provide the ClinicalTrials.gov identifier, NCT number (e.g., NCT ) for those trials. 10 NIH Certification of Compliance: RPPR

11 NIH Certification of Compliance: RPPR Screenshot

Record Retention for Clinical Trial Data Carefully consider requirements NIH Grantee Institution’s responsibility –Minimum of 3 years after date of submission of final expenditures report to NIH –May be additional durations specified under CFR as well Requirements apart from those associated with NIH grants 12

What if NIH has concerns about compliance? Extramural Program Official may generate a notification –PD/PI, Business Official, RP, NIH Grants Mgmt FDAAA Issues Report from PRS (Protocol Registration System; NLM) –Missing FDAAA-required fields & results Work quickly to respond and remedy –Bring trial and grant into compliance 13

Resources and Tips 14

NIH OER Resources “What NIH Grantees Need to Know about FDAAA” Step-by-step guidance Flowcharts for ascertaining ACTs and RP “At-a-glance” requirements FAQs for NIH Grantees 15

Tips: Take a Team Approach Be aware of your Institution’s approach/SOP Work as a team to identify ACTs and RPs –Sponsored research office, PI, Counsel –Work across institutions –Take actions early to clarify roles and responsibilities NIH’s role –Resources –Cannot make determinations or register/report results on behalf of Grantee or RP 16

Tip: Manage Risk Wisely Grantee Institutions as Sponsors –SOP? –Monitor compliance –All ACTs belong in Institutional account –Use personnel appropriately to fulfill FDAAA Not necessary to have a someone designated as RP in order for him/her to enter data Multi-user access, including user from outside of Institution –Implement appropriate record retention 17

Tips: Understand FDAAA Only the RP can register and report results –If trial is non-compliant, non-RP may not usurp RP’s role Be attentive to rulemaking 18

The NIH encourages registration and results reporting for all NIH-supported clinical trials, regardless of whether or not they are subject to FDAAA. 19